Department of Thoracic Surgery

XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors (2023) Heger L, Hatscher L, Liang C, Lehmann C, Amon L, Lühr JJ, Kaszubowski T, et al. Journal article Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression (2023) Hartmann P, Trufa D, Hohenberger K, Tausche P, Trump S, Mittler S, Geppert CI, et al. Journal article Spread through Air Spaces (STAS) in Solitary Pulmonary Metastases from Colorectal Cancer (CRC) (2022) Haj Khalaf M, Sirbu H, Hartmann A, Agaimy A, Dudek W, Higaze M, Rieker R Journal article WNT4 overexpression and secretion in thymic epithelial tumors drive an autocrine loop in tumor cells in vitro (2022) Zhang X, Schalke B, Kvell K, Kriegsmann K, Kriegsmann M, Graeter T, Preissler G, et al. Journal article Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma (2022) Gähler A, Trufa D, Chiriac MT, Tausche P, Hohenberger K, Brunst AK, Rauh M, et al. Journal article IL-9 Producing Tumor-Infiltrating Lymphocytes and Treg Subsets Drive Immune Escape of Tumor Cells in Non-Small Cell Lung Cancer (2022) Heim L, Yang Z, Tausche P, Hohenberger K, Chiriac MT, Kölle J, Geppert CI, et al. Journal article Pleural Resident Macrophages and Pleural IRA B Cells Promote Efficient Immunity Against Pneumonia by Inducing Early Pleural Space Inflammation (2022) Benard A, Podolska M, Czubayko F, Kutschick I, Klösch B, Jacobsen A, Naschberger E, et al. Journal article Reply by the Authors of the Original Article (2021) Dudek W, Schreiner W, Haj Khalaf M, Sirbu H Journal article, Letter Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections (2021) Bénard A, Jacobsen A, Brunner M, Krautz C, Klösch B, Swierzy I, Naschberger E, et al. Journal article A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results (2021) Wein A, Stöhr R, Kersting S, Siebler J, Merkel S, Busse D, Wolff K, et al. Journal article